Hypoxia inducing factor 1 alpha-transfected cardiac stem cells in repair of necrotic myocardium
10.3969/j.issn.2095-4344.2015.23.024
- VernacularTitle:缺氧诱导因子1a基因转染心脏干细胞修复坏死心肌：应用前景
- Author:
Sha LI
;
Shuren LI
;
Qianhui ZHANG
- Publication Type:Journal Article
- Keywords:
Heart;
Myocardial Infarction;
Hypoxia-Inducible Factor 1,alpha Subunit;
Stem Cell Transplantation
- From:
Chinese Journal of Tissue Engineering Research
2015;(23):3750-3754
- CountryChina
- Language:Chinese
-
Abstract:
BACKGROUND:Cardiac stem cels transplanted to the myocardial infarction area can effectively improve ventricular remodeling and promote heart function. But the survival rate of transplanted cels is lower in the infracted area under hypoxic microenvironment. Hypoxia inducing factor 1 alpha under anoxic conditions can stably express, and meanwhile increase the activity and survival ability of myocardial cels. OBJECTIVE:To elaborate the research progress in hypoxia inducing factor 1 alpha-transfected cardiac stem cels for treatment of myocardial infarction from the folowing aspects: cardiac stem cel characteristics, mechanism underlying myocardial protection of hypoxia inducing factor 1 alpha, selection of carriers and transplantation approach. METHODS: A computer-based search of CNKI and PubMed was performed for articles related to cardiac stem cels and hypoxia inducing factor 1 alpha published from January 2000 to January 2015. The keywords were “cardiac stem cels, hypoxia inducible factor 1(HIF-1a), gene delivery” in Chinese and English, respectively, which appeared in the title and abstract. Finaly, 37 relevant articles were enroled in result analysis. RESULTS AND CONCLUSION:Several studies have confirmed that hypoxia inducing factor 1 alpha can improve the survival rate of cardiac stem cels under anoxic conditions. Increasing evidences from animal experiments have shown that cardiac stem cels and hypoxia inducing factor 1 alpha exert protective and repairing effects on myocardial infarction. Currently, there is no successful report about hypoxia inducing factor 1 alpha gene transfection of cardiac stem cels, but relevant studies are proceeding. Gene modified cardiac stem cels are expected to be widely used in clinic.
